Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000818:Animals; D003042:Cocaine / Q000494:pharmacology; D004347:Drug Interactions; D004558:Electric Stimulation; D004878:Ergotamine / Q000494:pharmacology; D005260:Female; D006321:Heart / Q000187:drug effects; D008297:Male; D009278:Naphazoline / Q000494:pharmacology; D009411:Nerve Endings / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010109:Oxymetazoline / Q000494:pharmacology; D010275:Parasympathetic Nervous System / Q000187:drug effects; D010477:Perfusion; D010656:Phenylephrine / Q000494:pharmacology; D011817:Rabbits; D011955:Receptors, Drug; D013566:Sympathomimetics / Q000494:pharmacology*; D009435:Synaptic Transmission / Q000187:drug effects*
D000316:Adrenergic alpha-Agonists; D011955:Receptors, Drug; D013566:Sympathomimetics; D010656:Phenylephrine; D010109:Oxymetazoline; D009278:Naphazoline; D003042:Cocaine; D004878:Ergotamine; D009638:Norepinephrine